TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 5 March 1, 2011
(The next issue will be on March 15, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1LcGpRiwj-TTKweA_g5-527/
Abdel-Bakky MS, Hammad MA, Walker LA, Ashfaq MK (2011) Silencing of tissue factor by antisense deoxyoligonucleotide prevents monocrotaline/LPS renal injury in mice. Arch Toxicol.
http://www.ncbi.nlm.nih.gov/pubmed/21327618
Almagro D, Agramonte O, Castillo D, Zamora Y, Ballester JM (2011) Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia. Haemophilia 17:322-323.
http://www.ncbi.nlm.nih.gov/pubmed/21332884
Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A (2011) Recombinant Activated Factor VII Usage in Life Threatening Hemorrhage: A Pediatric Experience. Indian J Pediatr.
http://www.ncbi.nlm.nih.gov/pubmed/21328080
Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP (2011) Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21342367
Di Santo A, Amore C, Dell'elba G, Manarini S, Evangelista V (2011) Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21320285
Gringeri A, Fischer K, Karafoulidou A, Klamroth R, Lopez-Fernandez MF, Mancuso E (2011) Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21323801
Guglielmone H, Jarchum G, Minoldo S (2011) Liver transplantation in a patient with mild haemophilia A and low-titres of factor VIII inhibitors treated with recombinant factor VIIa. The first Argentinean case. Haemophilia 17:317-318.
http://www.ncbi.nlm.nih.gov/pubmed/21332883
Henriquez S, Calderon C, Quezada M, Oliva B, Bravo ML, Aranda E, . . . Owen GI (2011) Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI. J Cell Physiol.
http://www.ncbi.nlm.nih.gov/pubmed/21344386
Ji M, Yi S, Smith-Hurst H, Phillips P, Wu J, Hawthorne W, O'Connell P (2011) The Importance of Tissue Factor Expression by Porcine NICC in Triggering IBMIR in the Xenograft Setting. Transplantation.
http://www.ncbi.nlm.nih.gov/pubmed/21325994
Lin Y, Stanworth S, Birchall J, Doree C, Hyde C (2011) Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2:CD005011.
http://www.ncbi.nlm.nih.gov/pubmed/21328270
Margaritis P, Roy E, Faella A, Downey HD, Ivanciu L, Pavani G, . . . High KA (2011) Catalytic domain modification and viral gene delivery of activated Factor VII confers hemostasis at reduced expression levels and vector doses in vivo. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/21325603
Mitra B, Cameron PA, Parr MJ, Phillips L (2011) Recombinant factor VIIa in trauma patients with the 'triad of death'. Injury.
http://www.ncbi.nlm.nih.gov/pubmed/21345431
Poursafa P, Kelishadi R, Lahijanzadeh A, Modaresi M, Javanmard SH, Assari R, . . . Sadeghian B (2011) The relationship of air pollution and surrogate markers of endothelial dysfunction in a population-based sample of children. BMC Public Health 11:115.
http://www.ncbi.nlm.nih.gov/pubmed/21332998
Swystun LL, Mukherjee S, Levine M, Liaw PC (2011) The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal- and cell-based models. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21320281
Thabut D, Rudler M, Rousseau G, Poynard T (2011) Recombinant Activated factor VII in chronic liver diseases: should we be afraid of thromboembolic events? J Hepatol.
http://www.ncbi.nlm.nih.gov/pubmed/21349297
van der Poll T, Boer JD, Levi M (2011) The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis.
http://www.ncbi.nlm.nih.gov/pubmed/21330919
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 5 March 1, 2011
(The next issue will be on March 15, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1LcGpRiwj-TTKweA_g5-527/
Abdel-Bakky MS, Hammad MA, Walker LA, Ashfaq MK (2011) Silencing of tissue factor by antisense deoxyoligonucleotide prevents monocrotaline/LPS renal injury in mice. Arch Toxicol.
http://www.ncbi.nlm.nih.gov/pubmed/21327618
Almagro D, Agramonte O, Castillo D, Zamora Y, Ballester JM (2011) Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia. Haemophilia 17:322-323.
http://www.ncbi.nlm.nih.gov/pubmed/21332884
Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A (2011) Recombinant Activated Factor VII Usage in Life Threatening Hemorrhage: A Pediatric Experience. Indian J Pediatr.
http://www.ncbi.nlm.nih.gov/pubmed/21328080
Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP (2011) Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21342367
Di Santo A, Amore C, Dell'elba G, Manarini S, Evangelista V (2011) Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21320285
Gringeri A, Fischer K, Karafoulidou A, Klamroth R, Lopez-Fernandez MF, Mancuso E (2011) Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21323801
Guglielmone H, Jarchum G, Minoldo S (2011) Liver transplantation in a patient with mild haemophilia A and low-titres of factor VIII inhibitors treated with recombinant factor VIIa. The first Argentinean case. Haemophilia 17:317-318.
http://www.ncbi.nlm.nih.gov/pubmed/21332883
Henriquez S, Calderon C, Quezada M, Oliva B, Bravo ML, Aranda E, . . . Owen GI (2011) Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI. J Cell Physiol.
http://www.ncbi.nlm.nih.gov/pubmed/21344386
Ji M, Yi S, Smith-Hurst H, Phillips P, Wu J, Hawthorne W, O'Connell P (2011) The Importance of Tissue Factor Expression by Porcine NICC in Triggering IBMIR in the Xenograft Setting. Transplantation.
http://www.ncbi.nlm.nih.gov/pubmed/21325994
Lin Y, Stanworth S, Birchall J, Doree C, Hyde C (2011) Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2:CD005011.
http://www.ncbi.nlm.nih.gov/pubmed/21328270
Margaritis P, Roy E, Faella A, Downey HD, Ivanciu L, Pavani G, . . . High KA (2011) Catalytic domain modification and viral gene delivery of activated Factor VII confers hemostasis at reduced expression levels and vector doses in vivo. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/21325603
Mitra B, Cameron PA, Parr MJ, Phillips L (2011) Recombinant factor VIIa in trauma patients with the 'triad of death'. Injury.
http://www.ncbi.nlm.nih.gov/pubmed/21345431
Poursafa P, Kelishadi R, Lahijanzadeh A, Modaresi M, Javanmard SH, Assari R, . . . Sadeghian B (2011) The relationship of air pollution and surrogate markers of endothelial dysfunction in a population-based sample of children. BMC Public Health 11:115.
http://www.ncbi.nlm.nih.gov/pubmed/21332998
Swystun LL, Mukherjee S, Levine M, Liaw PC (2011) The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal- and cell-based models. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21320281
Thabut D, Rudler M, Rousseau G, Poynard T (2011) Recombinant Activated factor VII in chronic liver diseases: should we be afraid of thromboembolic events? J Hepatol.
http://www.ncbi.nlm.nih.gov/pubmed/21349297
van der Poll T, Boer JD, Levi M (2011) The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis.
http://www.ncbi.nlm.nih.gov/pubmed/21330919
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
